Skip to main content
. 2019 Jan 21;33(4):e22833. doi: 10.1002/jcla.22833

Table 1.

Comparisons of laboratory parameters among the ovarian cancer, benign ovarian disease, and healthy controls

Parameter Ovarian cancer Benign ovarian disease Healthy control P value
n 262 258 232
Age, y 43.48 ± 11.45 43.19 ± 9.46 42.82 ± 12.32 0.804
WBC, ×109/L 7.99 ± 3.48* 6.85 ± 2.29** 6.09 ± 1.09*** <0.001
Hb, g/L 105.58 ± 20.46* 124.50 ± 13.04** 131.98 ± 7.29*** <0.001
Neutrophils, ×109/L 5.76 ± 3.39* 4.21 ± 2.05** 3.43 ± 0.83*** <0.001
Lymphocytes, ×109/L 1.54 ± 0.66* 2.03 ± 0.71** 2.09 ± 0.45 <0.001
Monocytes, ×109/L 0.51 ± 0.20* 0.46 ± 0.16** 0.40 ± 0.10*** <0.001
CA‐125, U/mL 92.08 (34.15‐473.45)* 23.29 (13.10‐37.98)** 6.34 (4.06‐11.10)*** <0.001
dNLR 2.29 (1.50‐3.55)* 1.44 (1.14‐1.88)** 1.29 (1.06‐1.54)*** <0.001

Data are expressed as mean ± standard deviation or median (interquartile range).

CA‐125, carbohydrate antigen‐125; dNLR, derived neutrophil‐to‐lymphocyte ratio; Hb, hemoglobin; WBC, white blood cell count.

*

P < 0.05, ovarian cancer group vs benign ovarian disease group.

**

P < 0.05, ovarian cancer group vs healthy control group.

***

P < 0.05, benign ovarian disease group vs healthy control group.